[Good response of scleromyxedema and dermato-neuro syndrome to treatment with intravenous immunoglobulins].

Autor: Bielsa I; Servicio de Dermatología, Hospital Universitari Germans Trias i Pujol, Badalona, Universitat Autònoma de Barcelona, España. ibielsa.germanstrias@gencat.cat, Benvenutti F, Guinovart RM, Ferrándiz C
Jazyk: Spanish; Castilian
Zdroj: Actas dermo-sifiliograficas [Actas Dermosifiliogr] 2012 May; Vol. 103 (4), pp. 317-20. Date of Electronic Publication: 2011 Sep 13.
DOI: 10.1016/j.ad.2011.04.015
Abstrakt: Scleromyxedema is a potentially serious disease that can have various systemic complications. One of the most frequent forms of central nervous system involvement is dermato-neuro syndrome. High-dose intravenous immunoglobulins are among the drug treatments that have been used for this syndrome. We describe 2 patients with scleromyxedema, one of whom developed dermato-neuro syndrome. Both patients responded well to treatment with high-dose intravenous immunoglobulins. We suggest this therapy as a suitable first-line treatment for scleromyxedema and for its neurological complications.
(Copyright © 2011 Elsevier España, S.L. and AEDV. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: